Global Pharmaceutical Polymer Excipients Market Insights, Forecast to 2028

Market Analysis and Insights: Global Pharmaceutical Polymer Excipients Market
Due to the COVID-19 pandemic, the global Pharmaceutical Polymer Excipients market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Micro Crystalline Cellulose (MCC) accounting for % of the Pharmaceutical Polymer Excipients global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While OSDF (Oral Solid Dosage Form) segment is altered to an % CAGR throughout this forecast period.
China Pharmaceutical Polymer Excipients market size is valued at US$ million in 2021, while the US and Europe Pharmaceutical Polymer Excipients are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharmaceutical Polymer Excipients landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Pharmaceutical Polymer Excipients include Archer Daniel Midland (ADM), Evonik, BASF, Dow, Abitec Corporation, Cargill, Asahi Kasei, Accent Microcell and FMC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Pharmaceutical Polymer Excipients Scope and Segment
Pharmaceutical Polymer Excipients market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Polymer Excipients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Micro Crystalline Cellulose (MCC)
Hydroxypropyl Methylcellulose (HPMC)
Ethyl and Methyl Cellulose
Starch
Polyethylene Glycol
Segment by Application
OSDF (Oral Solid Dosage Form)
Capsules
Other
By Company
Archer Daniel Midland (ADM)
Evonik
BASF
Dow
Abitec Corporation
Cargill
Asahi Kasei
Accent Microcell
FMC
Shandong Guangda Technology
Tai'an Ruitai
Shandong Head
Huzhou Zhanwang
Anhui Shanhe
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE